Tau Protein Biosensors in the Diagnosis of Neurodegenerative Diseases

13Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Tau protein plays a crucial role in diagnosing neurodegenerative diseases. However, performing an assay to detect tau protein on a nanoscale is a great challenge for early diagnosis of diseases. Enzyme-linked immunosorbent assay (ELISA), western-blotting, and molecular-based methods, e.g., PCR and real-time PCR, are the most widely used methods for detecting tau protein. These methods are subject to certain limitations: the need for advanced equipment, low sensitivity, and specificity, to name a few. With the above said, it is necessary to discover advanced and novel methods for monitoring tau protein. Counted among remarkable approaches adopted by researchers, biosensors can largely eliminate the difficulties and limitations associated with conventional methods. The main objective of the present study is to review the latest biosensors developed to detect the tau protein. Furthermore, the problems and limitations of conventional diagnosis methods were discussed in detail.

Cite

CITATION STYLE

APA

Sadeghzadeh, J., Shahabi, P., Farhoudi, M., Ebrahimi-Kalan, A., Mobed, A., & Shahpasand, K. (2023). Tau Protein Biosensors in the Diagnosis of Neurodegenerative Diseases. Advanced Pharmaceutical Bulletin. Tabriz University of Medical Sciences. https://doi.org/10.34172/apb.2023.061

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free